ALKBH5 and central nervous system cancer: Furthermore, an ALKBH5 inhibitor IOX1, can suppress ALKBH5 activity through a cofactor 2-oxoglutarate oxygenase competitive manner to enhance the therapeutic efficacy of anti-PD-1 treatment in preclinical glioma mice models (83).